Intech Biopharm Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	16.8	198.65	77.73	64.82	220.48
Short-Term Investments	197.5	60	520	310	115
Cash & Short-Term Investments	214.3	258.65	597.73	374.82	335.48
Cash Growth	-17.15%	-56.73%	59.47%	11.73%	10.11%
Accounts Receivable	4.38	9.28	3.05	3.67	15.04
Other Receivables	2.59	9.83	8.7	7.94	7.94
Receivables	6.97	19.11	11.74	11.6	22.98
Inventory	116.48	63.86	41.53	51.82	59.87
Prepaid Expenses	65.38	68.65	43.62	40.7	33.74
Other Current Assets	-	0.06	0.41	0.13	4.26
Total Current Assets	403.13	410.32	695.02	479.06	456.33
Property, Plant & Equipment	1,403	1,885	1,900	2,009	2,090
Other Intangible Assets	4.89	3.86	4.88	4.8	4.62
Long-Term Deferred Tax Assets	24.77	24.77	24.77	24.77	24.77
Other Long-Term Assets	514.69	71.69	86.15	33.17	26.26
Total Assets	2,351	2,396	2,711	2,551	2,602
Accounts Payable	3.9	9.82	0.31	1.33	2.4
Accrued Expenses	-	28.82	19.24	23.71	20.82
Current Portion of Long-Term Debt	194.14	248.82	464.65	265.26	211.66
Current Portion of Leases	0.39	-	-	-	-
Current Unearned Revenue	12.94	81.18	78.54	78.31	78.99
Other Current Liabilities	31.95	18	5.99	5.23	9.35
Total Current Liabilities	243.32	386.64	568.73	373.82	323.22
Long-Term Debt	994.9	1,188	970.41	1,143	940.77
Long-Term Leases	0.6	-	-	-	-
Long-Term Unearned Revenue	8.84	5.53	2.35	-	-
Long-Term Deferred Tax Liabilities	0.02	-	-	-	-
Other Long-Term Liabilities	2.29	1.72	1.74	1.54	-
Total Liabilities	1,250	1,582	1,543	1,519	1,264
Common Stock	1,784	1,379	1,374	1,170	1,163
Additional Paid-In Capital	282.09	19.76	286.16	195.15	481.32
Retained Earnings	-959.57	-579.76	-488.08	-327.88	-301.76
Comprehensive Income & Other	-5.58	-5.16	-4.32	-5.13	-4.72
Shareholders' Equity	1,101	814.28	1,168	1,032	1,338
Total Liabilities & Equity	2,351	2,396	2,711	2,551	2,602
Total Debt	1,190	1,436	1,435	1,409	1,152
Net Cash (Debt)	-975.73	-1,178	-837.33	-1,034	-816.94
Net Cash Per Share	-6.45	-8.58	-6.95	-8.90	-8.03
Filing Date Shares Outstanding	162.83	137.94	137.41	116.96	116.28
Total Common Shares Outstanding	162.83	137.94	137.41	116.96	116.28
Working Capital	159.81	23.68	126.3	105.24	133.11
Book Value Per Share	6.76	5.90	8.50	8.82	11.50
Tangible Book Value	1,096	810.42	1,163	1,027	1,333
Tangible Book Value Per Share	6.73	5.87	8.46	8.78	11.46
Land	-	919.87	919.87	950.72	950.72
Buildings	-	791.07	790.24	798.32	810.2
Machinery	-	724.87	657.12	645.9	633.52

Source: S&P Global Market Intelligence. Standard template. Financial Sources.